About the Authors

Michael J Sorich, Nicolas Pottier, Wenjian Yang, Leo Kager, Gabriele Stocco, John C Panetta, Mary V Relling, Meyling H Cheok, William E Evans
Hematological Malignancies Program and the Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America

Michael J Sorich
Sansom Institute, University of South Australia, Adelaide, Australia

Nicolas Pottier
EA2679, Faculté de Médecine de Lille, Pole Recherche, Lille, France

Deqing Pei, Cheng Cheng
Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America

Leo Kager
Department of Hematology-Oncology, St. Anna Children's Hospital, Vienna, Austria

Gabriele Stocco
Instituto di Ricovero e Cura a Carattere Scientifico, Burlo Garofolo and University of Trieste, Trieste, Italy

John C Panetta, Ching-Hon Pui, Mary V Relling, Meyling H Cheok, William E Evans
University of Tennessee, Memphis, Tennessee, United States of America

Ching-Hon Pui
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America

Mary V Relling, William E Evans
Pharmacogenetics of Anticancer Agents Research Group, National Institutes of Health Pharmacogenetics Research Network, Memphis, Tennessee, United States of America, and Chicago, Illinois, United States of America

Corresponding Author

william.evans@stjude.org

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

MJS, C-HP, MHC, and WEE designed the experiments and the study. MJS, DP, WY, GS, CC, JCP, MVR, WEE, and MHC analyzed the data. C-HP enrolled and treated patients. NP wrote the first draft of the paper. MJS, WY, LK, GS, CC, C-HP, MVR, MHC, and WEE contributed to writing the paper. MHC collected gene expression and patient data for this study.